Stability of extemporaneously compounded amiloride nasal spray.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 09 04 2020
accepted: 25 06 2020
entrez: 11 7 2020
pubmed: 11 7 2020
medline: 9 9 2020
Statut: epublish

Résumé

Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride via nasal route, rapid onset of action can be achieved due to direct "nose-to-brain" access. Therefore, this study reports the formulation, physical, chemical, and microbiological stability of an extemporaneously prepared amiloride 2 mg/mL nasal spray. The amiloride nasal spray was prepared by adding 100 mg of amiloride hydrochloride to 50 mL of sterile water for injection in a sterile reagent bottle. A stability-indicating high-performance liquid chromatography (HPLC) method was developed and validated. Forced-degradation studies were performed to confirm the ability of the HPLC method to identify the degradation products from amiloride distinctively. The physical stability of the amiloride nasal spray was assessed by pH, clarity, and viscosity assessments. For chemical stability studies, samples of nasal sprays stored at room temperature were collected at time-points 0, 3 hr., 24 hr., and 7 days and were assayed in triplicate using the stability-indicating HPLC method. Microbiological stability of the nasal spray solution was evaluated for up to 7 days based on the sterility test outlined in United States Pharmacopoeia (USP) chapter 71. The stability-indicating HPLC method identified the degradation products of amiloride without interference from amiloride. All tested solutions retained over 90% of the initial amiloride concentration for the 7-day study period. There were no changes in color, pH, and viscosity in any sample. The nasal spray solutions were sterile for up to 7 days in all samples tested. An extemporaneously prepared nasal spray solution of amiloride hydrochloride (2 mg/mL) was physically, chemically, and microbiologically stable for 7 days when stored at room temperature.

Identifiants

pubmed: 32649677
doi: 10.1371/journal.pone.0232435
pii: PONE-D-20-10173
pmc: PMC7351165
doi:

Substances chimiques

Nasal Sprays 0
Amiloride 7DZO8EB0Z3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232435

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):79-88
pubmed: 21184587
J Psychiatr Res. 2007 Dec;41(11):906-17
pubmed: 17254605
N Engl J Med. 1990 Apr 26;322(17):1189-94
pubmed: 2157983
Int J Pharm. 1999 Jun 25;183(2):109-16
pubmed: 10361161
Analyst. 2012 Nov 21;137(22):5428-35
pubmed: 23024976
Sci Rep. 2016 Apr 28;6:25131
pubmed: 27121911
Am J Rhinol. 2008 Mar-Apr;22(2):125-9
pubmed: 18416966
J Psychopharmacol. 2019 Jan;33(1):101-108
pubmed: 29968500
J Anxiety Disord. 2012 Dec;26(8):833-43
pubmed: 23023162
Pharmacotherapy. 1981 Nov-Dec;1(3):179-87
pubmed: 6927605
Arch Gen Psychiatry. 2009 Jan;66(1):64-71
pubmed: 19124689
Arch Gen Psychiatry. 2001 Feb;58(2):114-9
pubmed: 11177112
Sci Rep. 2018 Feb 2;8(1):2258
pubmed: 29396481
Am J Health Syst Pharm. 2015 Sep 15;72(18):1544-54
pubmed: 26346210
Expert Opin Drug Deliv. 2011 Nov;8(11):1439-53
pubmed: 22004793
Arch Dis Child. 1995 Nov;73(5):427-30
pubmed: 8554360
Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):586-93
pubmed: 18040986
Pain. 2020 May;161(5):989-1004
pubmed: 31895269
Ther Deliv. 2014 Jun;5(6):709-33
pubmed: 25090283
P T. 2013 Jan;38(1):30-57
pubmed: 23599668
Pharm Res. 2013 Oct;30(10):2475-84
pubmed: 23135822
PLoS One. 2011 Apr 08;6(4):e18637
pubmed: 21494633
Pharmacotherapy. 1997 Mar-Apr;17(2):263-70
pubmed: 9085317
J Aerosol Med. 1997 Summer;10(2):147-58
pubmed: 10168532
Am J Psychiatry. 2005 Jun;162(6):1179-87
pubmed: 15930067
Am J Rhinol. 2004 Sep-Oct;18(5):291-9
pubmed: 15586800

Auteurs

Venkata Yellepeddi (V)

Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, Utah, United States of America.
Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, University of Utah, Salt Lake City, Utah, United States of America.

Casey Sayre (C)

Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, University of Utah, Salt Lake City, Utah, United States of America.
College of Pharmacy, Roseman University of Health Sciences, South Jordan, Utah, United States of America.

Anna Burrows (A)

College of Pharmacy, Roseman University of Health Sciences, South Jordan, Utah, United States of America.

Kevin Watt (K)

Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, Utah, United States of America.

Simon Davies (S)

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

John Strauss (J)

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Marco Battaglia (M)

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

Animals Rumen Methane Fermentation Cannabis
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility
Chloramphenicol Poloxamer Hypromellose Derivatives Gels Drug Stability
Powders Machine Learning Wettability Particle Size Viscosity

Classifications MeSH